Abstract:Background & AimsRosacea is an inflammatory skin disease. Case reports have shown rosacea as a comorbidity of inflammatory bowel disease (IBD), but no epidemiologic studies have examined rosacea and risk of subsequent IBD. The association between tetracycline use and risk of IBD was assessed, but this study produced limited findings. We examined the association between rosacea, use of tetracycline, and risk of incident Crohn’s disease (CD) and ulcerative colitis (UC).MethodsWe analyzed data from 96,314 participants in the Nurses’ Health Study II (1991–2011). Information on IBD was confirmed by medical review. Participants were asked in 2005 about their lifetime histories of clinician-diagnosed rosacea and year of diagnosis. Information on ever use of tetracycline was collected in 1993.ResultsDuring 1,856,587 person-years (1991–2011), we identified 149 cases of CD and 215 cases of UC. Rosacea was not associated with risk of UC. In contrast, rosacea was significantly associated with increased risk of subsequent CD (hazard ratio [HR], 2.20; 95% confidence interval [CI], 1.15–4.18), which appeared particularly stronger for a longer duration after a diagnosis of rosacea (Ptrend = .01). Tetracycline use was associated with increased risk of CD (HR, 1.56; 95% CI, 1.09–2.24) and UC (HR, 1.34; 95% CI, 1.00–1.80); there was a trend toward increased risk with increased duration of use (both Ptrend < .05) (1993–2011).ConclusionsOn the basis of an analysis of data from the Nurses’ Health Study II, ever use of tetracycline at baseline is associated with an increased risk of CD and UC. Personal history of rosacea is associated with an increased risk of only CD. Rosacea is an inflammatory skin disease. Case reports have shown rosacea as a comorbidity of inflammatory bowel disease (IBD), but no epidemiologic studies have examined rosacea and risk of subsequent IBD. The association between tetracycline use and risk of IBD was assessed, but this study produced limited findings. We examined the association between rosacea, use of tetracycline, and risk of incident Crohn’s disease (CD) and ulcerative colitis (UC). We analyzed data from 96,314 participants in the Nurses’ Health Study II (1991–2011). Information on IBD was confirmed by medical review. Participants were asked in 2005 about their lifetime histories of clinician-diagnosed rosacea and year of diagnosis. Information on ever use of tetracycline was collected in 1993. During 1,856,587 person-years (1991–2011), we identified 149 cases of CD and 215 cases of UC. Rosacea was not associated with risk of UC. In contrast, rosacea was significantly associated with increased risk of subsequent CD (hazard ratio [HR], 2.20; 95% confidence interval [CI], 1.15–4.18), which appeared particularly stronger for a longer duration after a diagnosis of rosacea (Ptrend = .01). Tetracycline use was associated with increased risk of CD (HR, 1.56; 95% CI, 1.09–2.24) and UC (HR, 1.34; 95% CI, 1.00–1.80); there was a trend toward increased risk with increased duration of use (both Ptrend < .05) (1993–2011). On the basis of an analysis of data from the Nurses’ Health Study II, ever use of tetracycline at baseline is associated with an increased risk of CD and UC. Personal history of rosacea is associated with an increased risk of only CD.

Tetracycline Use and Risk of Incident Skin Cancer: a Prospective Study

A Prospective Cohort Study Exploring the Joint Influence of Sunlight Exposure and Tanning Bed Use on Basal Cell Carcinoma, Squamous Cell Carcinoma, and Melanoma Risk

Abstract 4651: Interaction Between Outdoor Ultraviolet Radiation and Indoor Tanning Bed Use on Skin Cancer Risk

Statin Use and Risk of Skin Cancer

Data from Long-term Ultraviolet Flux, Other Potential Risk Factors, and Skin Cancer Risk: A Cohort Study

Association Between Antihypertensive Medications and Risk of Skin Cancer in People Older Than 65 Years: a Population-Based Study.

Cumulative ultraviolet radiation flux in adulthood and risk of incident skin cancers in women.

Risk of Dental Discoloration and Enamel Dysplasia in Children Exposed to Tetracycline and Its Derivatives

Rosacea, Use of Tetracycline, and Risk of Incident Inflammatory Bowel Disease in Women

Vitamin D Intake and Risk of Skin Cancer in US Women and Men.

Association Between the Use of Topical Calcineurin Inhibitors and the Risk of Cancer Among Patients with Atopic Dermatitis: A Nationwide, Population-Based, Retrospective Cohort Study

089 Intake of Vitamin A and Carotenoids in Relation to Risk of Cutaneous SCC in US Adults

Association of Vitamin A Intake with Cutaneous Squamous Cell Carcinoma Risk in the United States.

Nonmelanoma skin cancer in relation to ionizing radiation exposure among U.S. radiologic technologists

1315. Dental Discoloration and Enamel dysplasia after Tetracyclines Exposure in Children: A Nationwide Population-Based Study in Korea

Hydrochlorothiazide Use and Risk of Skin Cancer: A Population‐Based Retrospective Cohort Study

Supplemental Material from Long-term Ultraviolet Flux, Other Potential Risk Factors, and Skin Cancer Risk: A Cohort Study

Abstract 3491: COX-2 Inhibitor Use and Risk of Skin Cancer: Three Prospective Cohort Studies

Safety profiles of tetracycline-class drugs: a pharmacovigilance analysis of the FAERS database

Use of Thiazide Diuretics and Risk of All Types of Skin Cancers: An Updated Systematic Review and Meta-Analysis

Skin Cancer Risk of Narrow-Band UV-B (TL-01) Phototherapy: A Multi-Center Registry Study with 4,815 Patients